Abstract
BASF and the nutrition products distribution firm DIEM Labs have formed an agreement under which the German giant will introduce its first medical food. The pact is one of several recent chemical company efforts to expand in the health and nutrition market. BASF is not providing details on what the product is, but it was developed in the business unit that houses the company’s work in omega-3 chemistry, according to Charlotte Berg-Svendsen, strategic innovation and intellectual property manager for the division. The company describes the product as a “first-to-the-market” medical food product for patients with nonalcoholic fatty liver disease. “With this step, BASF is entering an attractive new market segment in the space between human nutrition and pharma,” says Francois Scheffler, head of the company’s human nutrition and pharma solutions business. Omega-3 fatty acids, which have several plant and animal sources, including fish and walnuts, are associated with human metabolic
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
